Struma ovarii classification

Revision as of 22:39, 15 October 2017 by Mmir (talk | contribs) (→‎Classification)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

Struma ovarii Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Struma ovarii from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

ECG

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Struma ovarii classification On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Struma ovarii classification

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Struma ovarii classification

CDC on Struma ovarii classification

Struma ovarii classification in the news

Blogs on Struma ovarii classification

Directions to Hospitals Treating Psoriasis

Risk calculators and risk factors for Struma ovarii classification

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aravind Reddy Kothagadi M.B.B.S[2]

Overview

Struma ovarii may be classified in to two subtypes, benign type and malignant type. Malignant Struma ovarii (MSO) are classified into three subtypes; classic variant of papillary thyroid carcinoma (cPTC), follicular variant of papillary thyroid carcinoma (FVPTC) and Follicular thyroid carcinoma.

Classification

Struma ovarii may be classified in to two subtypes: benign and malignant.

According to the classification proposed by the World Health Organization (WHO) in 2004 for thyroid carcinomas, malignant struma ovarii (MSO) is classified into three subtypes: [1]

References

  1. Schmidt J, Derr V, Heinrich MC, Crum CP, Fletcher JA, Corless CL, Nosé V (2007). "BRAF in papillary thyroid carcinoma of ovary (struma ovarii)". Am. J. Surg. Pathol. 31 (9): 1337–43. doi:10.1097/PAS.0b013e31802f5404. PMID 17721188.

Template:WH Template:WS